Jun 1, 2026
Second-generation anti-vascular endothelial growth factor (VEGF) therapies approved for the management of neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO) continue to be evaluated in ongoing clinical and real-world studies. Findings from these...
May 29, 2026
In this podcast, Drs. Dante Pieramici and Margaret Chang discuss utilizing implantable drug delivery systems in the management of a patient with nAMD.
To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box:
May 29, 2026
In this podcast, Drs. Dante Pieramici, Margaret Chang, and Jordan Graff discuss utilizing implantable drug delivery systems in the management of a patient with DME.
To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: